Showing 35,221 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Injectable & long-acting HIV treatment

FDA Defers Approval of First Long-Acting HIV Therapy, Surprising Everyone

Editor's pick
HIV and ID Observations
23 December 2019
Reproductive health

The Madrid Declaration – a tool to improve sexual and reproductive health in Europe

News
23 December 2019
Cancer

Cancer treatment can suppress immune function in people with HIV

News
23 December 2019
News about aidsmap

Thank you for 2019!

News
20 December 2019
News about aidsmap

NAM wins awards at nOscars 2019

News
20 December 2019
PrEP programmes & uptake

PrEP users in Scotland are almost all gay and bisexual men

News
19 December 2019
Treatment guidelines

What's New in the Guidelines?

Editor's pick
AIDSinfo
19 December 2019
Behaviour change interventions

Making the case for HIV literacy

Editor's pick
Interdisciplinary Research in Sexual Health Network
19 December 2019
PrEP programmes & uptake

Australia: Increased usage and confidence in antiretroviral PrEP for the prevention of HIV found in UNSW study

Editor's pick
University of New South Wales
19 December 2019
Pregnancy and vertical transmission

US: Prescribing practices for pregnant women with HIV not aligned with guidelines

Editor's pick
Healio
19 December 2019
Finance & funding

Global Fund Announces Record-High Funding Allocations To Countries To Fight AIDS, TB and Malaria

Editor's pick
Health Policy Watch
19 December 2019
Drug-resistant TB

TB Alliance responds to questions raised by activists in relation to pretomanid

Editor's pick
TB Online
19 December 2019
Religion & faith

Health kiosks expanding HIV services in Zimbabwe

Editor's pick
UNAIDS
19 December 2019
PrEP policies & guidelines

Urgent action needed on routine commissioning of PrEP

Editor's pick
Terrence Higgins Trust
18 December 2019
New & experimental HIV treatments

CytoDyn Signs Definitive Agreements with Vyera Pharmaceuticals to Commercialize Leronlimab in the U.S. for the Treatment of HIV

Editor's pick
CytoDyn press release
18 December 2019
PrEP programmes & uptake

PrEP Acceptable to Pregnant, Post-Partum Women at High HIV Risk

Editor's pick
Medscape (requires free registration)
18 December 2019
Child developmental issues

Children with HIV score below HIV-negative peers in cognitive, motor function tests

Editor's pick
EurekAlert
18 December 2019
Vaginal rings & topical PrEP

Most women in low- and middle-income countries find vaginal rings acceptable and easy to use

News
18 December 2019
The search for an HIV prevention vaccine

Is the world ready for an HIV vaccine?

Editor's pick
Devex
17 December 2019
Global health initiatives

UN #MeToo whistleblower sacked for alleged sexual and financial misconduct

Editor's pick
The Guardian
17 December 2019
Treatment interruptions

Many people living with HIV unwilling to interrupt treatment for prolonged periods during HIV cure trials

News
17 December 2019
Government, leadership & policy

Stigma, politics, and an epidemic: HIV in the Philippines

Editor's pick
The Lancet (requires free registration)
16 December 2019
Men who have sex with men (MSM)

First men go on trial under Nigeria's anti-homosexuality laws

Editor's pick
The Guardian
16 December 2019
PrEP policies & guidelines

England: Towards the routine commissioning of pre-exposure prophylaxis (PrEP)

Editor's pick
Local Government Association
16 December 2019